Nota
Updated Nomogram To Predict Pathologic Stage Of Prostate Cancer Given Prostate-specific Antigen Level, Clinical Stage, And Biopsy Gleason Score (partin Tables) Based On Cases From 2000 To 2005
Registro en:
International Braz J Urol. , v. 33, n. 4, p. 580 - 581, 2007.
16775538
2-s2.0-34848909052
Autor
Billis A.
Institución
Resumen
[No abstract available] 33 4 580 581 Epstein, J.I., Amin, M., Boccon-Gibod, L., Egevad, L., Humphrey, P.A., Mikuz, G., Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens (2005) Scand J Urol Nephrol Suppl, 216, pp. 34-63 Han, M., Partin, A.W., Pound, C.R., Epstein, J.I., Walsh, P.C., Long-term biochemical disease-free and cancer-specific survival following anatomic radicl retropubic prostatectomy. The 15-year Johns Hopkins experience (2001) Urol Clin North Am, 28, pp. 555-565 Chan, T.Y., Partin, A.W., Walsh, P.C., Epstein, J.I., Prognostic significance of Gleason score 4+3 tumor at radical prostatectomy (2000) Urology, 56, pp. 823-827 Eichelberger, L.E., Cheng, L., Does pT2b cancer exist? Critical appraisal of the 2002 TNM classification of prostate cancer (2004) Cancer, 100, pp. 2573-2576 Quintal, M.M., Magna, L.A., Guimaraes, M.S., Ruano, T., Ferreira, U., Billis, A., Prostate cancer pathologic pT2b (2002 TNM staging system): Does it exist? (2006) Int Braz J Urol, 32, pp. 43-47